125 related articles for article (PubMed ID: 29995202)
41. Distribution of saposin proteins (sphingolipid activator proteins) in lysosomal storage and other diseases.
Morimoto S; Yamamoto Y; O'Brien JS; Kishimoto Y
Proc Natl Acad Sci U S A; 1990 May; 87(9):3493-7. PubMed ID: 2110365
[TBL] [Abstract][Full Text] [Related]
42. Expression of prosaposin and its receptors in the rat cerebellum after kainic acid injection.
Li X; Nabeka H; Saito S; Shimokawa T; Khan MSI; Yamamiya K; Shan F; Gao H; Li C; Matsuda S
IBRO Rep; 2017 Jun; 2():31-40. PubMed ID: 30135931
[TBL] [Abstract][Full Text] [Related]
43. [Globoid cell leukodystrophy of adult. A first case in Poland].
Jastrzębski K; Czartoryska B; Klimek A
Neurol Neurochir Pol; 2013; 47(3):278-82. PubMed ID: 23821426
[TBL] [Abstract][Full Text] [Related]
44. Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease.
Bradová V; Smíd F; Ulrich-Bott B; Roggendorf W; Paton BC; Harzer K
Hum Genet; 1993 Sep; 92(2):143-52. PubMed ID: 8370580
[TBL] [Abstract][Full Text] [Related]
45. Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells.
Koochekpour S; Lee TJ; Sun Y; Hu S; Grabowski GA; Liu Z; Garay J
J Cell Biochem; 2008 Aug; 104(6):2272-85. PubMed ID: 18481277
[TBL] [Abstract][Full Text] [Related]
46. Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells.
Lee TJ; Sartor O; Luftig RB; Koochekpour S
Mol Cancer; 2004 Nov; 3():31. PubMed ID: 15548330
[TBL] [Abstract][Full Text] [Related]
47. Stimulation of acid ceramidase activity by saposin D.
Azuma N; O'Brien JS; Moser HW; Kishimoto Y
Arch Biochem Biophys; 1994 Jun; 311(2):354-7. PubMed ID: 8203897
[TBL] [Abstract][Full Text] [Related]
48. The function of sphingolipids in the nervous system: lessons learnt from mouse models of specific sphingolipid activator protein deficiencies.
Matsuda J; Yoneshige A; Suzuki K
J Neurochem; 2007 Nov; 103 Suppl 1():32-8. PubMed ID: 17986137
[TBL] [Abstract][Full Text] [Related]
49. Role of saposin C and D in auditory and vestibular function.
Lustig LR; Alemi S; Sun Y; Grabowski G; Akil O
Laryngoscope; 2016 Feb; 126(2):452-9. PubMed ID: 26198053
[TBL] [Abstract][Full Text] [Related]
50. An Asn > Lys substitution in saposin B involving a conserved amino acidic residue and leading to the loss of the single N-glycosylation site in a patient with metachromatic leukodystrophy and normal arylsulphatase A activity.
Regis S; Filocamo M; Corsolini F; Caroli F; Keulemans JL; van Diggelen OP; Gatti R
Eur J Hum Genet; 1999; 7(2):125-30. PubMed ID: 10196694
[TBL] [Abstract][Full Text] [Related]
51. Functional characterization of the postulated intramolecular sphingolipid activator protein domain of human acid sphingomyelinase.
Kölzer M; Ferlinz K; Bartelsen O; Hoops SL; Lang F; Sandhoff K
Biol Chem; 2004 Dec; 385(12):1193-5. PubMed ID: 15653433
[TBL] [Abstract][Full Text] [Related]
52. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside.
Hiraiwa M; Martin BM; Kishimoto Y; Conner GE; Tsuji S; O'Brien JS
Arch Biochem Biophys; 1997 May; 341(1):17-24. PubMed ID: 9143348
[TBL] [Abstract][Full Text] [Related]
53. A novel homozygous GALC variant has been associated with Krabbe disease in a consanguineous family.
Tuncer FN; Iseri SAU; Yapici Z; Demir M; Karaca M; Calik M
Neurol Sci; 2018 Dec; 39(12):2123-2128. PubMed ID: 30209698
[TBL] [Abstract][Full Text] [Related]
54. Prosaposin: threshold rescue and analysis of the "neuritogenic" region in transgenic mice.
Sun Y; Qi X; Witte DP; Ponce E; Kondoh K; Quinn B; Grabowski GA
Mol Genet Metab; 2002 Aug; 76(4):271-86. PubMed ID: 12208132
[TBL] [Abstract][Full Text] [Related]
55. Sphingolipid hydrolase activator proteins and their precursors.
Sano A; Hineno T; Mizuno T; Kondoh K; Ueno S; Kakimoto Y; Inui K
Biochem Biophys Res Commun; 1989 Dec; 165(3):1191-7. PubMed ID: 2610686
[TBL] [Abstract][Full Text] [Related]
56. Autophagy in Gaucher disease due to saposin C deficiency.
Tatti M; Motta M; Salvioli R
Autophagy; 2011 Jan; 7(1):94-5. PubMed ID: 20980829
[TBL] [Abstract][Full Text] [Related]
57. Mutation Update of ARSA and PSAP Genes Causing Metachromatic Leukodystrophy.
Cesani M; Lorioli L; Grossi S; Amico G; Fumagalli F; Spiga I; Filocamo M; Biffi A
Hum Mutat; 2016 Jan; 37(1):16-27. PubMed ID: 26462614
[TBL] [Abstract][Full Text] [Related]
58. A case of late variant form of infantile Krabbe disease with a partial deficiency of galactocerebrosidase.
Okada S; Kato T; Tanaka H; Takada K; Aramitsu Y
Brain Dev; 1988; 10(1):45-6. PubMed ID: 3369670
[TBL] [Abstract][Full Text] [Related]
59. Impaired prosaposin lysosomal trafficking in frontotemporal lobar degeneration due to progranulin mutations.
Zhou X; Sun L; Bracko O; Choi JW; Jia Y; Nana AL; Brady OA; Hernandez JCC; Nishimura N; Seeley WW; Hu F
Nat Commun; 2017 May; 8():15277. PubMed ID: 28541286
[TBL] [Abstract][Full Text] [Related]
60. Residual galactosylsphingosine (psychosine) beta-galactosidase activities and associated GALC mutations in late and very late onset Krabbe disease.
Harzer K; Knoblich R; Rolfs A; Bauer P; Eggers J
Clin Chim Acta; 2002 Mar; 317(1-2):77-84. PubMed ID: 11814461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
